Article
Blood-based epigenome-wide analyses of cognitive abilities
17 Jan 2022
Abstract excerpt
BACKGROUND: Blood-based markers of cognitive functioning might provide an accessible way to track neurodegeneration years prior to clinical manifestation of cognitive impairment and dementia. RESULTS: Using blood-based epigenome-wide analyses of general cognitive function, we show that individual differences in DNA methylation (DNAm) explain 35.0% of the variance in general cognitive function (g). A DNAm...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
